The National Center for Cancer Care and Research at Hamad Medical Corporation is the first regional, and internationally one of the first, radiation oncology centers to have an M6 CyberKnife Robotic Radiosurgery System.

Used for the treatment of both cancerous and non-cancerous tumors, this system is equipped with highly advanced state-of-the-art technology used for the delivery of high doses of radiation with extreme accuracy.

Unlike other radiotherapy systems, CyberKnife has the capability of tracking the location of the tumor very precisely during treatment, using very advanced hardware and software to target the tumor. This provides more accurate shaping of the dose to the tumor, whilst simultaneously sparing the surrounding healthy tissue, which will significantly improve outcomes for patients and reduce any short or long term side effects.

Whether or not treatment by CyberKnife is offered to a patient will depend on the recommendation of the multi-disciplinary team.